FDA Grants Priority Review to Genentech's Tecentriq in Combination with Chemotherapy for the Initial Treatment of Extensive-Stage Small Cell Lung Cancer - BioSpace

FDA Grants Priority Review to Genentech's Tecentriq in Combination with Chemotherapy for the Initial Treatment of Extensive-Stage Small Cell Lung Cancer  BioSpace

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2QDJt76